Clinigen (Clinigen Group) is a global pharmaceutical and services company with a unique combination of businesses focused on providing access to medicines to improve the quality of people's lives around the world.
Quantum Pharmaceutical (previously part of Quantum Pharma PLC) is now a Clinigen Group Company. Quantum Pharma PLC was acquired by Clinigen in November 2017.
The Clinigen Mission
Clinigen’s mission is to deliver the right medicine to the right patient at the right time. Operating in three areas of global medicine supply: clinical trials, unlicensed and licensed medicines, Clinigen’s goal is to improve the quality of people’s lives around the world.
The Clinigen Group operates in a complex regulatory environment and is the only company currently in existence that can globally manage access to medicines across all three routes (clinical trials, unlicensed and licensed medicines) worldwide.
As a part of the Clinigen Group, Quantum have expanded their available resource. The acquisition has developed Quantum Pharmaceuticals’ existing knowledge base and has given the company access to new potential global routes.
For further information regarding the Clinigen Group please visit the Clinigen website.